Ozempic and Wegovy, Novo Nordisk’s Weight Loss Drugs, Reshape Denmark’s Economy

Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.

​Read More Ozempic (Drug), Semaglutide (Drug), Wegovy, Obesity, Diabetes, Economic Conditions and Trends, Gross Domestic Product, Novo Nordisk A/S, Denmark